Infant, Premature
1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
2 programs1
Active TreatmentPhase 31 trial
Testosterone and Cortisol Levels in InfantsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Human BioSciencesActive Treatment
UNION therapeuticsMultimodal signal acquisitions
Human BioSciencesTestosterone and Cortisol Levels in Infants
Clinical Trials (3)
Total enrollment: 1,882 patients across 3 trials
Management of the PDA Trial
Start: Feb 2019Est. completion: May 2027836 patients
Phase 3Active Not Recruiting
Preliminary Study to the Conception of a Non-invasive Neonatal Monitoring System With Development of a Database
Start: Nov 2016Est. completion: Jun 2024746 patients
N/AUnknown
Testosterone and Cortisol Levels in Infants
Start: Oct 2015Est. completion: Feb 2017300 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.